Facts & Figures

Global headquarters

Aubagne, France

Legal structure

Sartorius Stedim Biotech S.A. is listed on the stock exchange in Paris, France. Sartorius AG holds approximately 74% of the share capital and around 85% of the voting rights of Sartorius Stedim Biotech S.A.

Annual sales Revenue 2018

1,212.2 million euros

- of which EMEA

42%

- of which Americas

35%

- of which Asia | Pacific

23%

Underlying EBITDA

Underlying EBITDA margin

342.4 million euros

28.2%

Capex ratio

14.6%

Number of employees (as Dec 31, 2018)

5,600